Commercial Engagement in Particle Accelerator Science
Consulting in Advanced Technologies
Accel-Link contributes an interesting lateral-thinking aspect to technical problem solving in the particle accelerator field. Through Dr. Dehnel’s exposure to many particle accelerator, ion source, beam diagnostic, and beam handling technologies applied to hundreds of different applications in semiconductor manufacture, medical imaging, medical therapy, contraband detection, gem stone enhancement, carbon-dating, materials testing, discovery science and etc …., Accel-Link is able to propose and work through solutions to technical accelerator-based problems, or to contribute to next generation particle accelerator products that benefit from ethical cross-fertilization of ideas. Dr. Dehnel is not necessarily an expert in accomplishing the implementation of each innovative technology solution proposed, but he facilitates the creation of teams with abilities to achieve this, or to link people, suppliers, experts and other resources to clients to accomplish their goals.
Leadership through Public Speaking
Public speaking engagements serve as a platform for disseminating knowledge and inspiring innovation within the particle accelerator community. Topics often addressed include advancements in accelerator technology, the impact of these innovations on healthcare and environmental sustainability, and future trends in the sector. By speaking at conferences, seminars, and workshops, Dr. Dehnel shares valuable insights and fosters a collaborative environment for scientific progress.
Advisory Roles on Technology Boards
Participation on advisory boards is an aspect of leadership in the particle accelerator field. Dr. Dehnel has served such advisory roles for companies in the areas of medical imaging, radioisotope production, accelerator related computing, and ion source & cyclotron manufacture. In terms of community organizations, Dr. Dehnel was a founding member of the Kootenay Association of Science and Technology (KAST), and the Task Force on Technology for the city of Nelson, BC, Canada. Advisory activities for academic institutions have included Board work for the Selkirk Technology Access Centre, and contributing to TRIUMF’s 20 Year Vision. Dr. Dehnel has also advised on various engineering, and science programmes at academic institutions. His work has also included being interviewed by national funding bodies such as NRC to aid them in their efforts to assess the performance of National Laboratories such as TRIUMF in the area of technology transfer. Another notable advisory initiative that Dr. Dehnel was invited to was to a meeting chaired by Mr. Wayne Wouters, Clerk of the Privy Council and Deputy Ministers Michael Horgan (Finance), John Knubley (Industry), Ian Shugart (Employment and Social Development), Serge Dupont (Natural Resources), Simon Kennedy (Trade) and Daphne Meredith (Western Economic Diversification), in a business roundtable to exchange views on the state of Canada’s business climate. The meeting took place on Friday, April 4th, 2014 from 9:30 a.m. to 11:30 a.m. , at 800 Burrard Street, room 1902 – Vancouver. In closing, it was an honour for Dr. Dehnel to be invited to the October 2009 symposium in Washington, DC, USA, which brought together stakeholders from across the spectrum of accelerator science and technology, and resulted in a substantive document: “Accelerators for America’s Future”.
https://science.osti.gov/-/media/hep/pdf/files/pdfs/Accel_for_Americas_Future_final_report.pdf
Collaborative Research Assignments
Research assignments and collaborations in particle accelerator science are geared towards enhancing the capabilities and applications of accelerators. These projects often involve partnerships with universities, research institutions, and private sector companies, focusing on areas such as ion implantation, advanced materials research, and biomedical applications. Through these collaborations, Dr. Dehnel aims to push the boundaries of what is currently possible with accelerator technologies.
Angel Investment in Innovative Ventures
Angel investment plays a crucial role in fostering innovation within the accelerator technology sphere. Investors focus on startups and new ventures that are developing groundbreaking applications of accelerator technology, such as new forms of cancer treatment or novel environmental cleanup solutions. By providing funding and financial backing, angel investors support the growth of these companies and the commercialization of new technologies, contributing to the overall advancement of the field. Accel-Link is keen to invest in young researchers, and to provide guidance through the start-up phase of companies that utilize particle accelerator technologies for applications that benefit society in an ethical and diverse manner.